The Danish pharmaceutical company has struggled in recent months to meet its lofty sales expectations.
obesity
Auto Added by WPeMatico
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of...
In early animal tests, the experimental TDN triggered weight loss without nausea or vomiting.
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea...
New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI...
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience...
People taking Amgen’s MariTide lost up to 20% of their body weight in a Phase II trial.
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU...
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean...
New research finds that ER visits related to semaglutide use might be on the rise.
